Literature DB >> 25079798

Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β.

Xiu-Lian Wang1, Ji Zeng2, Yang Yang3, Yan Xiong3, Zhi-Hua Zhang4, Mei Qiu3, Xiong Yan3, Xu-Ying Sun3, Qing-Zhang Tuo3, Rong Liu3, Jian-Zhi Wang3.   

Abstract

Abnormal hyperphosphorylation of microtubule-associated protein tau is involved in the pathogenesis of several neurodegenerative disorders including Alzheimer's disease (AD). Helicobacter pylori (H. pylori) infection has been reported to be related with a high risk of AD, but the direct laboratory evidence is lacking. Here we explored the effect of H. pylori infection on tau phosphorylation. The results showed that H. pylori filtrate induced significant tau hyperphosphorylation at several AD-related tau phosphorylation sites, such as Thr205, Thr231, and Ser404, both in mouse neuroblastoma N2a cells and rat brains with activation of glycogen synthase kinase-3β (GSK-3β). Application of GSK-3 inhibitors efficiently attenuated the H. pylori-induced tau hyperphosphorylation. Our data provide evidence supporting the role of H. pylori infection in AD-like tau pathology, suggesting that H. pylori eradication may be beneficial in the prevention of tauopathy.

Entities:  

Keywords:  Alzheimer's disease; Helicobacter pylori; glycogen synthase kinase-3β; tau hyperphosphorylation

Mesh:

Substances:

Year:  2015        PMID: 25079798     DOI: 10.3233/JAD-140198

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  26 in total

1.  TPPU protects tau from H2O2-induced hyperphosphorylation in HEK293/tau cells by regulating PI3K/AKT/GSK-3β pathway.

Authors:  En-Sheng Yao; Yan Tang; Xing-Hua Liu; Ming-Huan Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

2.  Long-term Helicobacter pylori infection does not induce tauopathy and memory impairment in SD rats.

Authors:  Huan Zhou; Ying Guo; Xing Li; Zheng-Yu Liuyang; Yang-Ping Shentu; Xiao-Peng Jing; Jia-Wei Liang; Xin-Wen Zhou; Xiao-Chuan Wang; Jian-Zhi Wang; Ji Zeng; Rong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

Review 3.  Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.

Authors:  Rong-Hong Ma; Yao Zhang; Xiao-Yue Hong; Jun-Fei Zhang; Jian-Zhi Wang; Gong-Ping Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

Review 4.  The Microbiome as a Modifier of Neurodegenerative Disease Risk.

Authors:  P Fang; S A Kazmi; K G Jameson; E Y Hsiao
Journal:  Cell Host Microbe       Date:  2020-08-12       Impact factor: 21.023

Review 5.  Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.

Authors:  Priyanka Nagu; Arun Parashar; Tapan Behl; Vineet Mehta
Journal:  J Mol Neurosci       Date:  2021-04-08       Impact factor: 3.444

6.  Probiotics, prebiotics and their role in Alzheimer's disease.

Authors:  Valeria DArgenio; Daniela Sarnataro
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

Review 7.  Role of neuroinflammation in neurodegeneration: new insights.

Authors:  Róisín M McManus; Michael T Heneka
Journal:  Alzheimers Res Ther       Date:  2017-03-04       Impact factor: 6.982

Review 8.  Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease.

Authors:  Barbara Miziak; Barbara Błaszczyk; Stanisław J Czuczwar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-13

Review 9.  Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.

Authors:  Steven A Harris; Elizabeth A Harris
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

10.  Analysis of microRNA and Gene Expression Profiles in Alzheimer's Disease: A Meta-Analysis Approach.

Authors:  Shirin Moradifard; Moslem Hoseinbeyki; Shahla Mohammad Ganji; Zarrin Minuchehr
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.